| # | Title | Journal | Year | Citations |
|---|
| 1 | Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus | Gut | 2013 | 4,813 |
| 2 | Post-acute COVID-19 syndrome | Nature Medicine | 2021 | 3,051 |
| 3 | AASLD guidelines for the treatment of hepatocellular carcinoma | Hepatology | 2018 | 2,932 |
| 4 | Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences | Gastroenterology | 2004 | 2,658 |
| 5 | Extrapulmonary manifestations of COVID-19 | Nature Medicine | 2020 | 2,300 |
| 6 | Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Gastroenterology | 2015 | 2,200 |
| 7 | International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas | Pancreatology | 2012 | 2,043 |
| 8 | Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial | Gastroenterology | 2007 | 1,986 |
| 9 | Updated Clinical Classification of Pulmonary Hypertension | Journal of the American College of Cardiology | 2009 | 1,919 |
| 10 | Human gut microbiota in obesity and after gastric bypass | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 1,641 |
| 11 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | Autophagy | 2021 | 1,430 |
| 12 | Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target | American Journal of Gastroenterology | 2015 | 1,425 |
| 13 | Multitarget Stool DNA Testing for Colorectal-Cancer Screening | New England Journal of Medicine | 2014 | 1,352 |
| 14 | Cholangiocarcinoma | Lancet, The | 2014 | 1,350 |
| 15 | ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease | American Journal of Gastroenterology | 2013 | 1,341 |
| 16 | Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies | Clinical Gastroenterology and Hepatology | 2015 | 1,199 |
| 17 | Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma | Journal of Hepatology | 2014 | 1,151 |
| 18 | Certolizumab Pegol for the Treatment of Crohn's Disease | New England Journal of Medicine | 2007 | 1,100 |
| 19 | Cholangiocarcinoma — evolving concepts and therapeutic strategies | Nature Reviews Clinical Oncology | 2018 | 1,051 |
| 20 | Diagnosis and management of primary sclerosing cholangitis | Hepatology | 2010 | 1,048 |
| 21 | Primary biliary cirrhosis | Hepatology | 2009 | 1,020 |
| 22 | Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States | Gastroenterology | 2011 | 1,006 |
| 23 | Modern diagnosis of GERD: the Lyon Consensus | Gut | 2018 | 991 |
| 24 | The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota | Gastroenterology | 2002 | 984 |
| 25 | Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma | Gastroenterology | 2013 | 978 |
| 26 | Endoplasmic reticulum stress in liver disease | Journal of Hepatology | 2011 | 952 |
| 27 | Biliary Tract Cancers | New England Journal of Medicine | 1999 | 933 |
| 28 | A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells | Nature Medicine | 2006 | 889 |
| 29 | The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients | Gastroenterology | 2004 | 880 |
| 30 | Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology | Gut | 2014 | 870 |
| 31 | ACG Clinical Guideline: Management of Crohn's Disease in Adults | American Journal of Gastroenterology | 2018 | 851 |
| 32 | Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab | Annals of Internal Medicine | 2007 | 849 |
| 33 | American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts | Gastroenterology | 2015 | 816 |
| 34 | Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study | Liver International | 2015 | 813 |
| 35 | Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease | Gastroenterology | 2015 | 725 |
| 36 | A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease | Gastroenterology | 2008 | 709 |
| 37 | Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome 1 ☆ | Gastroenterology | 2004 | 684 |
| 38 | Increased Prevalence and Mortality in Undiagnosed Celiac Disease | Gastroenterology | 2009 | 675 |
| 39 | Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia | Gastrointestinal Endoscopy | 2003 | 665 |
| 40 | PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis | Gut | 2005 | 655 |
| 41 | The safety of vedolizumab for ulcerative colitis and Crohn's disease | Gut | 2017 | 630 |
| 42 | Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci | Nature Genetics | 2016 | 617 |
| 43 | Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment | Hepatology | 2008 | 614 |
| 44 | The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years | Gut | 2009 | 607 |
| 45 | The Prevalence of Celiac Disease in the United States | American Journal of Gastroenterology | 2012 | 604 |
| 46 | High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis | Hepatology | 2009 | 603 |
| 47 | Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort | Gastroenterology | 2010 | 597 |
| 48 | Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis | American Journal of Gastroenterology | 2014 | 595 |
| 49 | Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial | Gastroenterology | 2007 | 586 |
| 50 | Clinical diagnosis and staging of cholangiocarcinoma | Nature Reviews Gastroenterology and Hepatology | 2011 | 572 |
